Director
DIN: 08721334
Manakkaparmbil Ramachandran Jithesh is currently associated with 2 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at MYTHON TECHNOLOGIES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08721334.Manakkaparmbil Ramachandran Jithesh is currently involved in 3 different roles. Their most recent position is with MEDCLAPP HEALTH CARE PRIVATE LIMITED as a Director. The first company Manakkaparmbil Ramachandran Jithesh was appointed to as a director was MYTHON TECHNOLOGIES LLP. Manakkaparmbil Ramachandran Jithesh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Manakkaparmbil Ramachandran Jithesh is currently associated with 2 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at MYTHON TECHNOLOGIES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08721334.Manakkaparmbil Ramachandran Jithesh is currently involved in 3 different roles. Their most recent position is with MEDCLAPP HEALTH CARE PRIVATE LIMITED as a Director. The first company Manakkaparmbil Ramachandran Jithesh was appointed to as a director was MYTHON TECHNOLOGIES LLP. Manakkaparmbil Ramachandran Jithesh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (0)
1y 4m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MEDCLAPP HEALTH CARE PRIVATE LIMITED | Director | 08-Feb-2021 |
| MEDCLAPP HEALTH CARE PRIVATE LIMITED | Individual Promoter | 08-Feb-2021 |